Terms: = Gastric cancer AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546 AND Prognosis
15 results:
1. cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors.
He S; Xia C; Li H; Cao M; Yang F; Yan X; Zhang S; Teng Y; Li Q; Chen W
Sci China Life Sci; 2024 Jan; 67(1):122-131. PubMed ID: 37755589
[TBL] [Abstract] [Full Text] [Related]
2. [Landscape of KRAS, BRAF, and PIK3CA Mutations and Clinical Features of EBV-Associated and Microsatellite Unstable gastric cancer].
Danishevich AM; Pospehova NI; Stroganova AM; Golovina DA; Nikulin MP; Kalinin AE; Nikolaev SE; Stilidi IS; Lyubchenko LN
Mol Biol (Mosk); 2023; 57(1):71-84. PubMed ID: 36976740
[TBL] [Abstract] [Full Text] [Related]
3. Nomogram-Based Prognostic Evaluation of gastric cancer Patients with Low Counts of Examined Lymph Nodes Outperforms the Predictive Ability of the 7
Sierzega M; Bobrzynski L; Kolodziejczyk P; Wallner G; Kulig J; Szczepanik A; ; Sierzega M; Bobrzynski L; Kolodziejczyk P; Wallner G; Kulig J; Szczepanik A; Dadan J; Drews M; Fraczek M; Jeziorski A; Krawczyk M; Starzynska T; Richter P
J Gastrointest Surg; 2023 Jan; 27(1):7-16. PubMed ID: 36138310
[TBL] [Abstract] [Full Text] [Related]
4. Radiomics signature for predicting postoperative disease-free survival of patients with gastric cancer: development and validation of a predictive nomogram.
Shi S; Miao Z; Zhou Y; Xu C; Zhang X
Diagn Interv Radiol; 2022 Sep; 28(5):441-449. PubMed ID: 36097638
[TBL] [Abstract] [Full Text] [Related]
5. Gastroenteropancreatic neuroendocrine neoplasms G3: Novel insights and unmet needs.
Shi M; Fan Z; Xu J; Yang J; Li Y; Gao C; Su P; Wang X; Zhan H
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188637. PubMed ID: 34678439
[TBL] [Abstract] [Full Text] [Related]
6. The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms.
Venizelos A; Elvebakken H; Perren A; Nikolaienko O; Deng W; Lothe IMB; Couvelard A; Hjortland GO; Sundlöv A; Svensson J; Garresori H; Kersten C; Hofsli E; Detlefsen S; Krogh M; Sorbye H; Knappskog S
Endocr Relat Cancer; 2021 Nov; 29(1):1-14. PubMed ID: 34647903
[TBL] [Abstract] [Full Text] [Related]
7. Association Between Lymph Node Ratio and Survival in Patients with Pathological Stage II/III gastric cancer.
Kano K; Yamada T; Yamamoto K; Komori K; Watanabe H; Hara K; Shimoda Y; Maezawa Y; Fujikawa H; Aoyama T; Tamagawa H; Yamamoto N; Cho H; Shiozawa M; Yukawa N; Yoshikawa T; Morinaga S; Rino Y; Masuda M; Ogata T; Oshima T
Ann Surg Oncol; 2020 Oct; 27(11):4235-4247. PubMed ID: 32424582
[TBL] [Abstract] [Full Text] [Related]
8. Mesenchymal Stem Cell Marker Expression in gastric cancer Stroma.
Numakura S; Uozaki H; Kikuchi Y; Watabe S; Togashi A; Watanabe M
Anticancer Res; 2019 Jan; 39(1):387-393. PubMed ID: 30591485
[TBL] [Abstract] [Full Text] [Related]
9. [Clinical characteristics and treatment strategies for early-stage primary gastric diffuse large B-cell lymphoma].
Qin Y; Liu P; Yang JL; Jin J; He XH; Wang WH; Fang H; Zhou SY; Zhou LQ; Song YW; Shi YK
Zhonghua Yi Xue Za Zhi; 2018 Jun; 98(24):1945-1950. PubMed ID: 29996288
[No Abstract] [Full Text] [Related]
10. Impact of the Charlson comorbidity index and prognostic nutritional index on prognosis in patients with early gastric cancer after endoscopic submucosal dissection.
Iwai N; Dohi O; Naito Y; Inada Y; Fukui A; Takayama S; Ogita K; Terasaki K; Nakano T; Ueda T; Okayama T; Yoshida N; Katada K; Kamada K; Uchiyama K; Ishikawa T; Handa O; Takagi T; Konishi H; Yagi N; Itoh Y
Dig Endosc; 2018 Sep; 30(5):616-623. PubMed ID: 29532961
[TBL] [Abstract] [Full Text] [Related]
11. FBXW7 expression is associated with prognosis and chemotherapeutic outcome in Chinese patients with gastric adenocarcinoma.
Li MR; Zhu CC; Ling TL; Zhang YQ; Xu J; Zhao EH; Zhao G
BMC Gastroenterol; 2017 May; 17(1):60. PubMed ID: 28464881
[TBL] [Abstract] [Full Text] [Related]
12. Preoperative serum levels of insulin-like growth factor-binding protein 2 predict prognosis of gastric cancer patients.
Hur H; Yu EJ; Ham IH; Jin HJ; Lee D
Oncotarget; 2017 Feb; 8(7):10994-11003. PubMed ID: 28036255
[TBL] [Abstract] [Full Text] [Related]
13. [Comparison of three lymph node staging systems in predicting overall survival for gastric cancer patients after radical resection].
Luo C; Zhang G; Wang W; Zhou Z; Zhang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1107-1112. PubMed ID: 27781245
[TBL] [Abstract] [Full Text] [Related]
14. Positive Lymph Node Ratio as an Indicator of prognosis and Local Tumor Clearance in N3 gastric cancer.
Komatsu S; Ichikawa D; Miyamae M; Kosuga T; Okamoto K; Arita T; Konishi H; Morimura R; Murayama Y; Shiozaki A; Kuriu Y; Ikoma H; Nakanishi M; Fujiwara H; Otsuji E
J Gastrointest Surg; 2016 Sep; 20(9):1565-71. PubMed ID: 27353383
[TBL] [Abstract] [Full Text] [Related]
15. Polymorphisms and a haplotype in heparanase gene associations with the progression and prognosis of gastric cancer in a northern Chinese population.
Li AL; Song YX; Wang ZN; Gao P; Miao Y; Zhu JL; Yue ZY; Xu HM
PLoS One; 2012; 7(1):e30277. PubMed ID: 22276173
[TBL] [Abstract] [Full Text] [Related]
